152 related articles for article (PubMed ID: 7612903)
1. Accrual to the Breast Cancer Prevention Trial by participating Community Clinical Oncology Programs: a panel data analysis.
Klabunde CN; Kaluzny AD
Breast Cancer Res Treat; 1995 Jul; 35(1):43-50. PubMed ID: 7612903
[TBL] [Abstract][Full Text] [Related]
2. Performance in quasi-firms: an example from the Community Clinical Oncology Program.
Lacey LM; Hynes DM; Kaluzny AD
J Health Hum Resour Adm; 1992; 14(3):307-26. PubMed ID: 10118501
[TBL] [Abstract][Full Text] [Related]
3. Community Clinical Oncology Program participation in the Breast Cancer Prevention Trial: factors affecting accrual.
Klabunde C; Kaluzny A; Ford L
Cancer Epidemiol Biomarkers Prev; 1995; 4(7):783-9. PubMed ID: 8672997
[TBL] [Abstract][Full Text] [Related]
4. Predicting the performance of a strategic alliance: an analysis of the Community Clinical Oncology Program.
Kaluzny AD; Lacey LM; Warnecke R; Hynes DM; Morrissey J; Ford L; Sondik E
Health Serv Res; 1993 Jun; 28(2):159-82. PubMed ID: 8514498
[TBL] [Abstract][Full Text] [Related]
5. Sustainability and performance of the National Cancer Institute's Community Clinical Oncology Program.
Carpenter WR; Fortune-Greeley AK; Zullig LL; Lee SY; Weiner BJ
Contemp Clin Trials; 2012 Jan; 33(1):46-54. PubMed ID: 21986391
[TBL] [Abstract][Full Text] [Related]
6. Accrual to National Cancer Institute-sponsored non-small-cell lung cancer trials: insights and contributions from the CCOP program.
Lyss AP; Lilenbaum RC
Clin Lung Cancer; 2009 Nov; 10(6):410-3. PubMed ID: 19900858
[TBL] [Abstract][Full Text] [Related]
7. Evaluating organizational design to assure technology transfer: the case of the Community Clinical Oncology Program.
Kaluzny AD; Ricketts T; Warnecke R; Ford L; Morrissey J; Gillings D; Sondik EJ; Ozer H; Goldman J
J Natl Cancer Inst; 1989 Nov; 81(22):1717-25. PubMed ID: 2681795
[TBL] [Abstract][Full Text] [Related]
8. The effects of managed care and competition on community-based clinical research.
Carpenter WR; Weiner BJ; Kaluzny AD; Domino ME; Lee SY
Med Care; 2006 Jul; 44(7):671-9. PubMed ID: 16799362
[TBL] [Abstract][Full Text] [Related]
9. Assuring access to state-of-the-art care for U.S. minority populations: the first 2 years of the Minority-Based Community Clinical Oncology Program.
Kaluzny A; Brawley O; Garson-Angert D; Shaw J; Godley P; Warnecke R; Ford L
J Natl Cancer Inst; 1993 Dec; 85(23):1945-50. PubMed ID: 8230286
[TBL] [Abstract][Full Text] [Related]
10. Clinical trials in the community. The community clinical oncology program experience.
Cobau CD
Cancer; 1994 Nov; 74(9 Suppl):2694-700. PubMed ID: 7954289
[TBL] [Abstract][Full Text] [Related]
11. Organizational and physician factors associated with patient enrollment in cancer clinical trials.
Jacobs SR; Weiner BJ; Reeve BB; Weinberger M; Minasian LM; Good MJ
Clin Trials; 2014 Oct; 11(5):565-75. PubMed ID: 24902923
[TBL] [Abstract][Full Text] [Related]
12. The Community Clinical Oncology Program (CCOP) story: review of community oncologists' experiences with clinical research trials in cancer with an emphasis on the CCOP of the National Cancer Institute between 1982 and 1987.
Frelick RW
J Clin Oncol; 1994 Aug; 12(8):1718-23. PubMed ID: 8040683
[TBL] [Abstract][Full Text] [Related]
13. Effect of state-mandated insurance coverage on accrual to community cancer clinical trials.
Ellis SD; Carpenter WR; Minasian LM; Weiner BJ
Contemp Clin Trials; 2012 Sep; 33(5):933-41. PubMed ID: 22683991
[TBL] [Abstract][Full Text] [Related]
14. Achieving high cancer control trial enrollment in the community setting: an analysis of the Community Clinical Oncology Program.
Jacobs SR; Weiner BJ; Minasian LM; Good MJ
Contemp Clin Trials; 2013 Mar; 34(2):320-5. PubMed ID: 23295315
[TBL] [Abstract][Full Text] [Related]
15. Using a community cancer treatment trials network for cancer prevention and control research: challenges and opportunities.
Kaluzny AD; Lacey LM; Warnecke R; Morrissey JP; Sondik E; Ford L
Cancer Epidemiol Biomarkers Prev; 1994; 3(3):261-9. PubMed ID: 8019377
[TBL] [Abstract][Full Text] [Related]
16. Implementing community-based provider participation in research: an empirical study.
Teal R; Bergmire DM; Johnston M; Weiner BJ
Implement Sci; 2012 May; 7():41. PubMed ID: 22568935
[TBL] [Abstract][Full Text] [Related]
17. Ecological analysis of the first generation of community clinical oncology programs.
Schopler JH
Health Serv Res; 1993 Apr; 28(1):69-95. PubMed ID: 8463110
[TBL] [Abstract][Full Text] [Related]
18. Reforming the community research program: from Community Clinical Oncology Program to the National Cancer Institute Community Oncology Research Program.
Zon RT
Am Soc Clin Oncol Educ Book; 2014; ():e116-9. PubMed ID: 24857089
[TBL] [Abstract][Full Text] [Related]
19. Role of biology and prevention in aerodigestive tract cancers.
Greenwald P; Stern HR
J Natl Cancer Inst Monogr; 1992; (13):3-14. PubMed ID: 1389693
[TBL] [Abstract][Full Text] [Related]
20. Enrollment of adolescents and young adults onto SWOG cancer research network clinical trials: A comparative analysis by treatment site and era.
Roth ME; Unger JM; O'Mara AM; Lewis MA; Budd T; Johnson RH; Pollock BH; Blanke C; Freyer DR
Cancer Med; 2020 Mar; 9(6):2146-2152. PubMed ID: 32009305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
